SCHEMBL6760243

SCHEMBL6760243

Cc1ccc(C(=O)NCl)cc1Nc1nc(Cl)nc(Cl)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.42
HDAC8 Q9BY41 6/20 0.40
KMT2A Q03164 1/20 0.40
HDAC1 Q13547 3/20 0.40
HDAC6 Q9UBN7 3/20 0.40
TSHR P16473 1/20 0.40
MAPK14 Q16539 4/20 0.39
NFKB1 P19838 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK3 P27361 1/20 0.39
LMNA P02545 1/20 0.39
SCN9A Q15858 1/20 0.39
ABL1 P00519 1/20 0.39
PDGFRB P09619 1/20 0.39
BCR P11274 1/20 0.39
PDGFRA P16234 1/20 0.39
KCNQ3 O43525 1/20 0.39
KCNQ2 O43526 1/20 0.39
KCNE1 P15382 1/20 0.39
KCNQ1 P51787 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13938683 0.90 MAPK14 (0.47) AKR1C3MAPK14MAPK11SCN9A
SCHEMBL3243118 0.84 LCK (0.49) AKR1C3MAPK14MAPK3
SCHEMBL3267755 0.81 HPGD (0.55) KMT2AMAPK3LMNAPOLB
SCHEMBL19175102 0.80 SCN9A (0.52) MAPK14MAPK11SCN9A
SCHEMBL3240053 0.79 KDM4E (0.58) HDAC8KMT2AHDAC1HDAC6LMNA
SCHEMBL8973678 0.76 RAPGEF4 (0.54) KMT2ATSHRNFKB1POLB
SCHEMBL13938681 0.74 MAPK14 (0.54) MAPK14MAPK11
SCHEMBL9010642 0.73 CA12 (0.46) TSHRNFKB1
SCHEMBL13938780 0.73 POLB (0.46) KMT2AMAPK14ABL1PDGFRBBCR
SCHEMBL12229805 0.70 MAPK14 (0.57) MAPK14MAPK11MAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1409463-A1 N-HETEROCYCLIC INHIBITORS OF TNF-ALPHA EXPRESSION Bristol-Myers Squibb Company (US) 2004-04-21 EP disclosed
WO-2003002542-A1 N-HETEROCYCLIC INHIBITORS OF TNF-ALPHA EXPRESSION BRISTOL-MYERS SQUIBB COMPANY (US) 2003-01-09 WO disclosed